Effect of Comorbidities and Risk Factors on Outcomes and Ivabradine's Effects in Patients With Chronic Systolic Heart Failure in the SHIFT Trial

被引：0
作者：
Boehm, Michael [1 ]
Borer, Jeffrey S. [2 ]
Ford, Ian [3 ]
Komajda, Michel [4 ]
Robertson, Michele [3 ]
Tavazzi, Luigi [5 ]
Swedberg, Karl [6 ]
机构：
[1] Univ Saarlandes Kliniken, Homburg, Germany
[2] Suny Downstate Med Ctr, New York, NY USA
[3] Univ Glasgow, Glasgow, Lanark, Scotland
[4] Univ Paris 06, Paris, France
[5] Maria Cecilia Hosp, Cotignola, Italy
[6] Univ Gothenburg, Gothenburg, Sweden
来源：
JOURNAL OF CARDIAC FAILURE | 2015年 / 21卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
090
引用
收藏
页码：S46 / S46
页数：1
相关论文
共 50 条
  • [31] THE PREVALENCE AND CORRELATED RISK FACTORS OF ARRHYTHMIA IN PATIENTS WITH CHRONIC SYSTOLIC HEART FAILURE
    Yu Shengbo
    HEART, 2011, 97
  • [32] The effects of ivabradine on left atrial electromechanical function in patients with systolic heart failure
    Serkan Ozturk
    Selçuk Öztürk
    Fatma Hizal Erdem
    Alim Erdem
    Selim Ayhan
    İbrahim Dönmez
    Mehmet Yazıcı
    Journal of Interventional Cardiac Electrophysiology, 2016, 46 : 253 - 258
  • [33] Estimation of Decrements of Utility Associated With Hospitalizations in a Population With Heart Failure From the Systolic Heart Failure Treatment With the If Inhibitor Ivabradine Trial (SHIFT)
    Krotneva, Stanimira
    Kansal, Anuraag R.
    Zheng, Ying
    Patel, Harshali K.
    Kielhorn, Adrian
    Bohm, Michael
    Tavazzi, Luigi
    Ford, Ian
    CIRCULATION, 2016, 134
  • [34] Efficacy of ivabradine therapy on right heart parameters and prognosis in patients with severe systolic chronic heart failure
    Tumasyan, L. R.
    Adamyan, K. G.
    Chilingaryan, A. L.
    EUROPEAN HEART JOURNAL, 2012, 33 : 808 - 808
  • [35] Non-adherence to ivabradine and placebo and outcomes in chronic heart failure: an analysis from SHIFT
    Boehm, Michael
    Lloyd, Suzanne M.
    Ford, Ian
    Borer, Jeffrey S.
    Ewen, Sebastian
    Laufs, Ulrich
    Mahfoud, Felix
    Lopez-Sendon, Jose
    Ponikowski, Piotr
    Tavazzi, Luigi
    Swedberg, Karl
    Komajda, Michel
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 (06) : 672 - 683
  • [36] Effect of Ivabradine on Readmission: A Post-Hoc Bayesian Analysis of 30-day Readmission Rates in the Systolic Heart Failure Treatment with the If Inhibitor Ivabradine Trial (SHIFT)
    Krotneva, Stanmira
    Kansal, Anuraag R.
    Ishak, K. Jack
    Kielhorn, Adrian
    Patel, Harshali
    Borer, Jeffery S.
    JOURNAL OF CARDIAC FAILURE, 2015, 21 (08) : S107 - S107
  • [37] Effects of ivabradine on endothelial function, aortic properties and ventricular-arterial coupling in chronic systolic heart failure patients
    Bonadei, Ivano
    Sciatti, Edoardo
    Vizzardi, Enrico
    Fabbricatore, Davide
    Pagnoni, Mattia
    Rossi, Laura
    Carubelli, Valentina
    Lombardi, Carlo M.
    Metra, Marco
    CARDIOVASCULAR THERAPEUTICS, 2018, 36 (03)
  • [38] The Effects of Ivabradine on Left Ventricular Synchronization and Tei Index in Patients with Systolic Heart Failure
    Erdem, Fatma Hizal
    Ozturk, Serkan
    Ozturk, Selcuk
    Erdem, Alim
    Ayhan, Selim
    Ozturk, Mustafa
    Donmez, Ibrahim
    Baltaci, Davut
    Yazici, Mehmet
    ACTA CARDIOLOGICA SINICA, 2017, 33 (01) : 58 - 65
  • [39] Clinical profiles and outcomes of patients with chronic heart failure and diabetes: efficacy and safety of ivabradine. a shift study analysis
    Komajda, M.
    Tavazzi, L.
    Swedberg, K.
    Bohm, M.
    Borer, J. S.
    Robertson, M.
    Ford, I.
    EUROPEAN JOURNAL OF HEART FAILURE, 2014, 16 : 42 - 42
  • [40] Risk factors and comorbidities in a community-wide sample of patients hospitalized with acute systolic or diastolic heart failure: The Worcester Heart Failure Study
    Chinali, Marcello
    Joffe, Samuel W.
    Aurigemma, Gerard P.
    Makam, Raghavendra
    Meyer, Theo E.
    Goldberg, Robert J.
    CORONARY ARTERY DISEASE, 2010, 21 (03) : 137 - 143
12345